Technetium-99m is the single most widely used radioactive tracer in medical imaging, involved in tens of millions of diagnostic procedures worldwide each year. It gets injected in tiny amounts, attached to different carrier molecules that steer it toward specific organs or tissues, and then a gamma camera captures the radiation it emits to produce functional images of the body. The range of conditions it helps diagnose is remarkably broad, from blocked coronary arteries and bone fractures to kidney obstruction, blood clots in the lungs, and hidden infections. What makes it so versatile is less about one killer application and more about a lucky combination of physical properties that let chemists attach it to almost anything a doctor wants to see.
Heart Imaging
Cardiac perfusion imaging is probably the best-known use of technetium-99m and one of the highest-volume nuclear medicine procedures performed anywhere. The tracer most commonly used is technetium-99m sestamibi (often sold under the brand name Cardiolite). It works by accumulating in heart muscle cells in proportion to blood flow: healthy tissue with good blood supply lights up, while areas fed by narrowed or blocked arteries appear dim or absent. Clinical trials have shown that the various imaging protocols for sestamibi provide diagnostic and prognostic information comparable to older thallium-201 imaging, with the bonus of higher-quality images and greater certainty in reading them.1PubMed. Myocardial perfusion imaging with technetium-99m-sestamibi: comparative analysis of available imaging protocols
The practical payoff for patients is real. In a study of patients with stable chest pain, those who had a normal sestamibi scan experienced cardiac events at a rate of just 0.5% over the following year, compared with 7% among those whose scans were abnormal. The scan’s ability to predict who would go on to have a heart attack or need a procedure held up even after accounting for other risk factors like exercise stress test results.2PubMed. Exercise technetium-99m sestamibi tomography for cardiac risk stratification of patients with stable chest pain Because the tracer does not redistribute quickly through the heart muscle after injection, imaging can be done at a convenient time after the stress test rather than in a frantic rush, which is a logistical advantage for busy nuclear medicine departments.3PubMed. Technetium-99m-sestamibi myocardial perfusion imaging in detection of coronary artery disease: comparison between initial (1-hour) and delayed (3-hour) postexercise images
Bone Scans
If you have ever had a full-body bone scan, the tracer was almost certainly a technetium-99m-labeled diphosphonate compound, most commonly MDP (methylene diphosphonate). These molecules chemically latch onto hydroxyapatite, the mineral that makes bone hard, concentrating wherever bone is actively being remodeled or repaired.4Journal of Nuclear Medicine. Dynamic Bone Imaging with 99mTc-Labeled Diphosphonates and 18F-NaF: Mechanisms and Applications Research using autoradiography has shown that the tracer deposits specifically at the mineralization front of bone and at tiny spaces around bone cells, but not near the cells that break bone down. This means the scan highlights spots of new bone formation, whether from a healing fracture, a metastatic tumor provoking the bone to react, an infection, or arthritis.5Oral Surgery, Oral Medicine, Oral Pathology. 99mTc-MDP accumulation mechanisms in bone
That sensitivity is the scan’s great strength and its limitation. A bone scan will pick up abnormalities that are invisible on a plain X-ray weeks earlier, which makes it valuable for detecting cancer spread to bone, stress fractures in athletes, and subtle infections. But because any process that increases bone turnover shows up as a “hot spot,” the scan cannot always tell you why the bone is active. Doctors typically use the pattern, location, and clinical context to narrow down the cause, and sometimes follow up with CT or MRI for more anatomic detail.
Brain Perfusion Studies
Technetium-99m HM-PAO (also called exametazime, brand name Ceretec) is a lipophilic compound that crosses the blood-brain barrier and gets trapped inside brain cells in proportion to blood flow. Once inside, it converts to a form that cannot easily leave, so the image represents a snapshot of blood flow at the moment of injection. This makes it useful for evaluating strokes, epilepsy (pinpointing a seizure focus), and dementia.
One striking application is confirming brain death. In a study of patients with severe brain injury, the tracer showed no uptake in the brain in 16 out of 17 studies performed on clinically brain-dead patients, and in 9 out of 11 studies on patients suspected of brain death who had complicating conditions that made the clinical diagnosis uncertain.6PubMed. Cerebral perfusion imaging with technetium-99m HM-PAO in brain death and severe central nervous system injury Every patient who was not clinically brain dead showed at least some tracer uptake, even when the study was otherwise abnormal. The scan essentially answers a stark yes-or-no question: is blood reaching the brain? When combined with quantitative measurements, the technique can also map cerebral blood flow values that correlate well with established methods, and the measurements are reproducible enough for clinical monitoring.7PubMed. Noninvasive measurement of cerebral blood flow with (99m)Tc-hexamethylpropyleneamine oxime single-photon emission computed tomography and 1-point venous blood sampling
Lung Perfusion and Pulmonary Embolism
Technetium-99m macroaggregated albumin (MAA) is the standard tracer for lung perfusion scans. The particles are slightly larger than the capillaries in the lungs, so after injection they temporarily lodge in the pulmonary capillary bed in proportion to blood flow. Areas downstream of a blood clot receive no particles and appear as cold spots on the image.8PubMed Central. Tc-99m macro aggregated albumin scintigraphy – indications other than pulmonary embolism: A pictorial essay This perfusion scan is usually combined with a ventilation scan (using a different inhaled tracer or gas) to create the classic “V/Q scan” for diagnosing pulmonary embolism. The logic is simple: if air gets to a part of the lung but blood does not, a clot is the likely culprit.
The MAA particles are harmless and break down within hours, restoring normal capillary flow. Beyond pulmonary embolism, lung perfusion scans have other uses: assessing how much functional lung tissue remains before surgery, evaluating congenital heart disease with abnormal blood flow patterns, and planning radiation therapy for lung cancer to spare the best-perfused tissue.
Kidney Function
For evaluating kidney function and drainage, technetium-99m MAG3 (mercaptoacetyltriglycine) is the workhorse tracer. After injection, it is rapidly extracted from the blood by the kidneys and excreted into the urine, so a gamma camera watching over time can measure how efficiently each kidney clears the tracer and whether urine drains properly into the bladder. Normal ranges for MAG3 clearance and the shape of the time-activity curve have been defined by age and sex, giving doctors a way to compare an individual patient’s kidneys against expected performance.9PubMed. 99mTc-MAG3 renography: normal values for MAG3 clearance and curve parameters, excretory parameters, and residual urine volume
This is especially useful in situations where a structural scan like ultrasound shows a dilated kidney but cannot tell you whether the dilation is causing real obstruction or is just a harmless anatomic variant. A MAG3 renogram, sometimes combined with a diuretic challenge, answers the functional question: is urine actually getting stuck? It is also used to monitor transplanted kidneys, evaluate renovascular hypertension, and split kidney function before surgery when one kidney needs to be removed.
Thyroid and Parathyroid Imaging
Technetium-99m pertechnetate, the simplest chemical form of the isotope, is taken up by the thyroid gland because it mimics iodide at the cellular level. A thyroid scan with pertechnetate shows the overall size, shape, and function of the gland and can distinguish “hot” nodules (overactive, rarely cancerous) from “cold” nodules (inactive, warranting further evaluation). The scan is quick, involves a low radiation dose, and does not require the longer wait times associated with iodine-based thyroid imaging.
For parathyroid disease, the approach is cleverer. Sestamibi, the same tracer used for heart imaging, happens to accumulate in overactive parathyroid glands and wash out more slowly than from thyroid tissue. By comparing early and late images, or by subtracting a pertechnetate thyroid image from a sestamibi image, surgeons can localize a parathyroid adenoma before the operation. Sensitivity for single adenomas is high, in the range of roughly 89% to 98%, though it drops considerably for parathyroid hyperplasia, where multiple glands are enlarged, with detection rates around 47% to 58%.10PubMed. Comparison of parathyroid imaging with technetium-99m-pertechnetate/sestamibi subtraction, double-phase technetium-99m-sestamibi and technetium-99m-sestamibi SPECT That gap matters clinically, because surgeons operate differently when they expect one bad gland versus four.
Sentinel Lymph Node Mapping in Cancer
When a patient has breast cancer or melanoma, one of the most important staging questions is whether cancer cells have reached the nearby lymph nodes. Rather than removing an entire chain of nodes and dealing with the side effects, surgeons can inject technetium-99m sulfur colloid near the tumor. The tiny radioactive particles travel through the lymphatic vessels and lodge in the first node that drains the tumor site. In the operating room, a handheld gamma probe detects the radioactive node, allowing the surgeon to remove just that one node and send it for pathology.
The technique is remarkably reliable. In a large single-institution series of over 2,300 breast cancer patients who received technetium-99m sulfur colloid injections, the sentinel node was successfully identified in 99.8% of cases.11PubMed Central. Intraoperative Injection of Technetium-99m Sulfur Colloid for Sentinel Lymph Node Biopsy in Breast Cancer Patients: A Single Institution Experience A validation study using subareolar injection reported a 98.4% identification rate.12Journal of the American College of Surgeons. Concordance and validation study of sentinel lymph node biopsy for breast cancer using subareolar injection of blue dye and technetium 99m sulfur colloid In melanoma, filtered technetium-99m sulfur colloid allows clear visualization of the lymphatic drainage pattern and good retention in the sentinel node, improving the success of intraoperative localization.13PubMed. Use of sentinel node lymphoscintigraphy in malignant melanoma If the sentinel node is clean, the patient is usually spared a full lymph node dissection.
Gallbladder Disease and GI Bleeding
Technetium-99m HIDA (hepatobiliary iminodiacetic acid) scans, also called cholescintigraphy, are a go-to test when acute cholecystitis is suspected. The tracer is taken up by liver cells and secreted into the bile ducts just like natural bile. If the gallbladder fills with tracer, it is not obstructed; if it does not fill within an hour or so, the cystic duct is blocked, which is the hallmark of acute cholecystitis. In a series of 105 patients with upper abdominal pain, abnormal HIDA scans correlated with gallbladder disease in 100% of those who went to surgery, and the scan also flagged common bile duct stones in most patients who had them.14PubMed. The diagnosis of acute gallbladder disease by technetium-99m-labelled HIDA hepatobiliary scanning
Another GI application uses technetium-99m-labeled red blood cells to find the source of gastrointestinal bleeding. After re-injecting the patient’s own red cells tagged with the isotope, a gamma camera watches the abdomen over time. If blood is leaking into the gut, the radioactive cells pool at the bleeding site and show up as a growing hot spot. The test can detect bleeding rates as low as a fraction of a milliliter per minute, making it more sensitive than angiography for intermittent bleeds. It often guides the next step, whether that is endoscopy, angiographic embolization, or surgery.
Tracking Down Hidden Infections
When a patient has a fever of unknown origin, or when a clinician suspects osteomyelitis or inflammatory bowel disease, technetium-99m HM-PAO-labeled white blood cells offer a way to find the problem without exploratory procedures. The patient’s own white blood cells are drawn, tagged with the tracer in a lab, and re-injected. Because white blood cells naturally migrate to sites of infection or inflammation, the radioactive label follows them there. The technique has proven especially valuable in children with suspected inflammatory bowel disease, serving as a reliable, minimally invasive screening method that can confirm or rule out active disease and spare kids from unnecessary endoscopy.15PubMed Central. Tc-99m Labeled HMPAO white Blood Cell Scintigraphy in Pediatric Patients
When combined with SPECT/CT (a hybrid scanner that fuses the functional nuclear image with an anatomic CT scan), labeled leukocyte imaging becomes even more precise. The CT component pins the abnormal tracer uptake to a specific bone, joint, or soft-tissue structure, resolving ambiguity that might exist on the nuclear images alone.16Journal of Nuclear Medicine. Usefulness of Hybrid SPECT/CT in 99mTc-HMPAO–Labeled Leukocyte Scintigraphy for Bone and Joint Infections
Why This Particular Isotope Dominates
Technetium-99m’s dominance is not an accident of history. It emits a 140-keV gamma ray, which is energetic enough to escape the body and reach the detector but not so energetic that it blasts through the camera without being captured. That energy sits in a sweet spot for the sodium iodide crystals used in standard gamma cameras. It has a half-life of about six hours: long enough to complete a scan, short enough that the radiation dose to the patient fades quickly. And it decays by emitting only gamma rays (via isomeric transition), with no beta particles, so the patient receives imaging photons without the tissue-damaging charged radiation that other isotopes produce.
On the chemistry side, technetium is a transition metal with flexible bonding behavior, meaning it can be attached to a wide variety of carrier molecules. Researchers have developed chelating agents and ligand systems that lock the isotope onto peptides, antibodies, colloids, phosphonates, and small organic molecules, each engineered to reach a different target in the body.17PubMed Central. Effect of chelators on the pharmacokinetics of (99m)Tc-labeled imaging agents for the prostate-specific membrane antigen (PSMA) Many of these labeling kits are simple enough that a hospital technologist can prepare a dose in minutes by adding saline generator eluate to a vial, shaking it, and drawing it up. That ease of preparation sets technetium-99m apart from tracers that require an on-site cyclotron or complex multi-step synthesis.
Use in Children
Pediatric nuclear medicine relies heavily on technetium-99m, in part because of its favorable dosimetry in small bodies. A dedicated phase I-II trial evaluated technetium-99m sestamibi in 78 children and adolescents for cardiac imaging. The estimated radiation doses and pharmacokinetic behavior turned out to be similar to what would be predicted from adult data scaled by body mass, and all patients tolerated the tracer without serious adverse effects.18Journal of Nuclear Medicine. A phaseI-II, open-label, multi-center trial to determine the dosimetry and safety of Technetium Tc99m Sestamibi in pediatric subjects Younger children received slightly higher effective doses per unit of injected activity compared with adolescents, which is expected given their smaller body size, but the absolute doses remained within ranges considered safe for diagnostic imaging.
Beyond cardiac imaging, technetium-99m scans in children are routine for evaluating kidney obstruction, Meckel’s diverticulum (a common cause of painless GI bleeding in kids, detected with technetium-99m pertechnetate because the tracer concentrates in ectopic gastric mucosa), bone infections, and the labeled white blood cell studies for inflammatory bowel disease mentioned earlier. The short half-life is especially reassuring for parents worried about radiation exposure in their child.
Supply Chain Fragility
For all its clinical dominance, technetium-99m has a supply chain that has proven surprisingly fragile. The isotope itself is obtained from the decay of molybdenum-99, which is produced in a handful of aging nuclear research reactors around the world. Twice in recent years the global supply has faced serious disruption: once in 2009, when two major reactors shut down simultaneously without warning, and again in 2020, when pandemic-related flight restrictions interrupted the shipment of molybdenum-99 from production sites to hospitals.19Nature Reviews Physics. Future of 99Mo reactor-independent supply
These crises forced hospitals to postpone scans, substitute less ideal tracers, or ration doses. The broader nuclear medicine community has since explored alternative production methods, including cyclotrons and electron linear accelerators, that could supplement or eventually replace the reactor-based supply. None of these alternatives has yet scaled to meet global demand, but the vulnerability of the current system has made diversification a priority for governments and industry alike.
New Frontiers in Technetium-99m Chemistry
The traditional technetium-99m radiopharmaceuticals are perfusion agents: they show where blood is flowing or where a tissue is metabolically active, but they do not tell you much about what specific molecules are present on a cell’s surface. Newer research is pushing toward receptor-targeted imaging, where the tracer is designed to bind a specific biological target the way a key fits a lock. Existing chelator and ligand systems already used for perfusion agents have been modified with biomolecular targeting groups to enable molecular imaging with technetium-99m.20Frontiers in Chemical Biology. Receptor-targeted technetium-99m radiopharmaceuticals: increasing access to molecular imaging in healthcare
One example involves prostate cancer. Researchers have developed urea-based small molecules that target prostate-specific membrane antigen (PSMA) and can be labeled with technetium-99m using different chelating strategies. The choice of chelator changes how the tracer distributes through the body and how much reaches the tumor, so the chemistry is not just academic: it directly affects whether the scan works.17PubMed Central. Effect of chelators on the pharmacokinetics of (99m)Tc-labeled imaging agents for the prostate-specific membrane antigen (PSMA) Other teams have developed bifunctional chelating agents that allow a single technetium-99m complex to carry two targeting molecules simultaneously, potentially boosting binding affinity to tumor markers like integrins.21Scientific Reports. Development of a hydroxamamide-based bifunctional chelating agent to prepare technetium-99m-labeled bivalent ligand probes If these approaches pan out, they could bring some of the molecular specificity currently associated with PET tracers into the far more widely available SPECT infrastructure, expanding access to targeted imaging in hospitals that cannot afford or maintain a cyclotron.